Doktor axborotnomasi 2025, №1.1 (118)
Maqola mavzusi
FEATURES OF INTERLEUKINS IN THE DEVELOPMENT OF HEART COMPLICATIONS IN CHILDREN WITH DIABETES AFTER COVID-19 INFECTION (100-102)
Mualliflar
A. A. Sadirkhodjaeva, D. T. Ashurova
Muassasa
Tashkent pediatric medical institute, Tashkent, Uzbekistan
Annotatsiya
The article describes research on the study of interleukins indicators in the development of heart complications in children with diabetes after COVID-19 infection. Thus, in type 1 diabetics, there was an increase in interleukin 1, 10, and TNF alpha, but in the main group of children, the increase in the concentrations of these cytokines was more pronounced in the presence of COVID-19 infection.
Kalit so'zlar
diabetes mellitus, complications, interleukins, COVID-19, heart.
Adabiyotlar
1. Andersen K.G., Rambaut A., Lipkin W.I., et al. (2022). "The proximal origin of SARS-CoV-2". Nature Medicine, 28(3), 450–455. DOI: 10.1038/s41591-022-01807-4. 2. Arentz M., Yim E., Klaff L., et al. (2021). "Characteristics and outcomes of 21 critically ill patients with COVID 19 in Washington State". Journal of the American Medical Association, 326(16), 1144–1152. DOI: 10.1001/ jama.2021.4326. 3. Cherubini V et al. COVID-19 and type 1 diabetes: Increased risk of severe diabetic ketoacidosis. Diabetes Re search and Clinical Practice. 2021. DOI: 10.1016/j.diabres.2021.108902. 4. Choi B., Choudhary M.C., Regan J., et al. Persistence of viral RNA, infectious virus, and sequelae in patients with severe COVID-19 // New England Journal of Medicine. 2021. Vol. 385, No. 6. P. 531–533. DOI: 10.1056/ NEJMc2031670. 5. Clerkin KJ et al. COVID-19 and cardiovascular disease. Journal of the American College of Cardiology. 2020. DOI: 10.1016/j.jacc.2020.03.031. 6. Han M.S., Seong M.W., Kim N., et al. (2022). "Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19". Journal of the American Medical Association Pediatrics, 176(4), 395–400. DOI: 10.1001/ jamapediatrics.2022.0368. 7. Rubino F et al. New-onset diabetes in COVID-19. New England Journal of Medicine. 2020. DOI: 10.1056/ NEJMc2018688. 8. Whittaker E et al. Clinical characteristics of MIS-C associated with SARS-CoV-2. New England Journal of Medi cine. 2020. DOI: 10.1056/NEJMoa2020209.